MoneyWorks4Me

Jenburkt Pharmaceuticals board to consider buy back of equity shares

05 Sep 2017 Evaluate

Jenburkt Pharmaceuticals has informed that a meeting of the Board of Directors of the Company is scheduled to be held on September 09, 2017, to consider matters related to Buyback of the fully paid-up equity shares of the Company including matters related/ incidental thereto and any other matter as the Board of Directors may decide during the course of the meeting.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1237.65
Cipla 1313.80
Lupin 1957.00
Zydus Lifesciences 1117.30
View more..